This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other respiratory conditions originating in the perinatal period
P16_OTH_RESPI_COND_ORIGINA_PERINA_PERIOD
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
52 |
4. Check minimum number of eventsNone |
52 |
5. Include endpointsNone |
52 |
6. Filter based on genotype QC (FinnGen only) |
52 |
Control definitions (FinnGen only)
- Control exclude
- P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P2
- Name in latin
- Aliae condiciones respiratoriae origine perinatales
Similar endpoints
↥List of similar endpoints to
Other respiratory conditions originating in the perinatal period
based on the number of shared cases.
Similar with more cases:
- Respiratory and cardiovascular disorders specific to the perinatal period
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3839 | 1774 | 2065 |
| Only index persons | 1696 | 755 | 941 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.06 |
| Only index persons | 0.03 | 0.03 | 0.04 |
| Median age at first event (years) | |||
| Whole population | - | 0.01 | 0.01 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 52 | 33 | 19 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 0.05 | 0.01 | 0.11 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
13
57
2.57
1.98
1.9
1.9
pmol/l
118.5
96.0
—
7
32
(3000991) Gas panel - Venous blood
19
103
2.20
1.82
5.9
16.8
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
13
3.94
1.68
4.4
4.2
umol/l
20.2
21.5
—
5
13
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
25
2.92
1.62
2.9
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
14
3.65
1.58
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
14
3.65
1.58
1.2
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
53
2.24
1.35
3.4
2.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
53
2.24
1.35
3.3
2.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
6
23
2.68
1.33
2.2
1.3
g/l
0.2
0.2
—
6
23
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
6
23
2.68
1.33
2.2
1.3
g/l
1.0
1.1
—
6
23
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
19
116
1.89
1.27
28.3
12.1
mmol/l
24.4
24.0
0.30
19
116
(3022313) Gas panel - Capillary blood
18
108
1.90
1.26
27.4
12.9
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
20
2.53
1.11
3.8
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
20
2.53
1.11
3.8
1.4
—
—
—
0
0
(44790049)
6
27
2.26
0.94
1.8
2.3
—
—
—
0
0
(44790047)
6
27
2.26
0.94
1.8
2.3
—
—
—
0
0
(44790048)
6
27
2.26
0.94
1.8
2.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
27
2.26
0.94
3.5
1.9
—
—
—
0
0
(44806118)
6
27
2.26
0.94
1.8
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
30
226
1.63
0.89
10.0
14.2
mmol/l
6.2
5.8
0.20
25
208
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
30
2.02
0.86
1.8
2.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
31
1.95
0.83
1.8
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
22
2.29
0.78
1.0
1.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
140
1.59
0.78
28.3
21.2
mmol/l
25.1
24.5
0.57
20
140
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
11
66
1.75
0.74
3.4
2.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
27
207
1.51
0.69
25.3
20.8
mmol/l
1.3
1.2
0.93
27
200
(3024354) Oxygen [Partial pressure] in Venous blood
16
109
1.58
0.69
4.9
16.8
kpa
4.9
5.3
0.47
16
109
(3011397) Hemoglobin [Presence] in Urine by Test strip
7
105
0.58
0.68
8.7
3.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
27
1.85
0.67
1.2
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
20
146
1.50
0.63
3.5
13.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
9
57
1.61
0.59
2.9
2.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
15
186
0.68
0.55
5.7
6.4
ml/min/173m2
116.6
117.1
—
9
107
(3037467) Urinalysis macro (dipstick) panel - Urine
20
234
0.70
0.53
6.6
4.5
—
—
—
0
0
(3015736) pH of Urine
10
134
0.64
0.53
6.8
3.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
77
0.58
0.51
1.8
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
5
79
0.56
0.51
1.4
7.3
—
1.2
—
0
23
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
35
371
0.69
0.50
5.6
10.6
u/l
23.0
25.2
0.34
35
349
(3018010) Neutrophils/100 leukocytes in Blood
32
264
1.41
0.50
4.5
13.1
%
44.8
46.4
0.29
32
252
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
27
217
1.39
0.49
24.4
17.2
mmol/l
1.3
1.2
1.13
27
204
(3022096) Basophils/100 leukocytes in Blood
30
246
1.39
0.48
4.4
14.1
%
0.6
0.6
0.04
30
235
(3006598) pH of Arterial cord blood
8
52
1.55
0.46
1.0
1.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
54
1.49
0.45
1.6
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
32
267
1.37
0.44
4.3
13.2
e9/l
2.8
2.6
0.11
24
211
(40768797) Stomach Pathology biopsy report
5
31
1.59
0.43
1.2
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8
108
0.65
0.43
2.5
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
109
0.65
0.43
1.8
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
44
391
1.48
0.43
9.9
10.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
32
1.54
0.42
1.8
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
15
0.00
0.42
0.0
3.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
15
0.00
0.42
0.0
3.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
15
0.00
0.42
0.0
9.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
0
15
0.00
0.42
0.0
1.3
—
1204.1
—
0
9
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
14
0.00
0.42
0.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
14
0.00
0.42
0.0
1.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
14
0.00
0.42
0.0
5.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
9
116
0.69
0.41
8.1
2.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
43
432
0.71
0.41
4.8
4.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
6.4
—
58.6
—
0
17
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
137
0.70
0.39
3.6
2.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
32
270
1.34
0.39
4.5
13.2
%
40.7
38.3
0.44
32
260
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
39
1.53
0.38
1.7
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
25
205
1.31
0.37
5.2
16.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
32
274
1.30
0.33
5.1
16.6
e9/l
3.7
3.4
0.25
24
212
(3006504) Eosinophils/100 leukocytes in Blood
30
255
1.29
0.32
4.5
13.7
%
2.7
3.0
0.47
30
242
(3005719) IgG [Mass/volume] in Serum or Plasma
7
51
1.36
0.32
1.7
7.2
g/l
9.1
7.6
—
7
51
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
13
99
1.34
0.30
2.0
4.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
22
181
1.28
0.30
2.1
2.6
mmol/l
1.3
1.4
1.89
17
169
(3006315) Basophils [#/volume] in Blood
30
257
1.27
0.29
4.5
13.2
e9/l
0.0
0.0
1.10
22
193
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
19
210
0.78
0.29
3.4
5.1
u/l
241.0
147.8
1.49
19
202
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
35
307
1.27
0.27
3.0
3.1
pmol/l
14.6
14.4
0.21
30
276
(3015377) Calcium [Moles/volume] in Serum or Plasma
12
92
1.32
0.26
1.5
2.8
mmol/l
2.4
2.4
0.09
12
82
(3037522) Nuclear Ab [Titer] in Serum
5
37
1.32
0.24
1.4
1.5
—
520.0
—
0
6
(3023511) Choriogonadotropin [Units/volume] in Urine
5
37
1.32
0.24
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
38
1.28
0.23
2.6
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
10
76
1.32
0.23
7.0
6.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
10
0.00
0.22
0.0
12.3
—
92.4
—
0
10
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
31.1
—
0.7
—
0
10
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
10
0.00
0.22
0.0
7.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.22
0.0
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
10
0.00
0.22
0.0
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.7
—
253.2
—
0
11
(3000093) Morphology [Interpretation] in Blood Narrative
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
12
0.00
0.21
0.0
4.6
—
0.2
—
0
5
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
30
263
1.21
0.21
5.0
14.7
e9/l
0.2
0.2
0.67
22
209
(3024471) HLA-A [Type]
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
6
48
1.22
0.20
1.7
2.8
g/l
0.9
1.0
—
6
48
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
135
0.80
0.20
2.3
2.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
41
409
0.79
0.19
21.5
21.8
%
13.4
13.2
0.57
41
403
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
57
1.20
0.19
1.0
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
10
79
1.26
0.17
1.6
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
30
266
1.18
0.17
5.0
15.6
e9/l
0.0
0.0
0.00
21
187
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
75
0.73
0.17
1.2
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
125
1.20
0.16
2.9
2.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
29
257
1.17
0.16
4.7
13.2
e9/l
0.6
0.6
0.62
21
193
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
77
1.14
0.16
2.3
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
7
83
0.77
0.16
1.4
4.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
7
81
0.80
0.16
1.1
2.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
11
89
1.23
0.15
1.2
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
89
1.23
0.15
2.3
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
18
154
1.18
0.15
1.3
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
220
1.16
0.15
2.5
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
12
100
1.19
0.12
1.8
2.7
ug/g
38.4
59.4
0.82
12
76
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
18
157
1.14
0.11
2.6
5.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
44
1.09
0.10
1.6
2.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
45
1.07
0.10
1.6
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
45
1.07
0.10
1.6
2.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
55
1.05
0.09
1.7
8.7
%
136.0
168.7
—
6
55
(1761868) Lipid panel - Serum or Plasma
6
55
1.05
0.09
1.0
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
6
69
0.81
0.08
1.7
4.3
u/l
110.2
60.2
—
6
61
(3018677) aPTT in Platelet poor plasma by Coagulation assay
7
80
0.81
0.07
2.6
13.5
s
29.7
32.1
—
7
80
(3018418) pH of Serum or Plasma
10
85
1.15
0.07
1.2
2.8
—
7.4
—
0
12
(3044889) 12 lead EKG panel
16
143
1.10
0.05
2.2
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
13
116
1.09
0.03
2.3
5.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
18
164
1.07
0.03
3.3
3.1
mmol/mol
34.1
36.0
0.43
18
148
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
133
1.01
0.00
2.9
2.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
14
137
0.97
0.00
6.6
15.4
umol/l
76.1
37.5
0.92
14
129
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
16
148
1.05
0.00
9.9
5.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
14
136
0.98
0.00
10.9
4.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
42
397
1.05
0.00
16.8
15.4
mg/l
28.4
23.5
0.39
29
282
(3001122) Ferritin [Mass/volume] in Serum or Plasma
22
210
1.00
0.00
3.5
3.5
ug/l
27.9
49.3
1.83
22
194
(3007164) IgA [Mass/volume] in Serum or Plasma
21
199
1.01
0.00
2.0
1.7
g/l
1.1
1.4
0.73
15
104
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
5.7
—
0
5
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
92
0.92
0.00
2.0
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
9
0.00
0.00
0.0
3.4
—
2.8
—
0
9
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
5
50
0.95
0.00
1.4
2.8
u/l
185.0
370.4
—
5
50
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
5.8
—
280.6
—
0
5
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
5.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
52
0.91
0.00
1.8
12.1
g/l
2.1
2.8
—
5
52
(3042733) HLA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
6
63
0.90
0.00
2.7
14.5
%
87.5
89.7
—
6
63
(3020491) Glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
5.4
—
0
5
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
8
0.00
0.00
0.0
5.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.8
—
24.6
—
0
5
(3013290) Carbon dioxide [Partial pressure] in Blood
0
9
0.00
0.00
0.0
1.8
—
4.9
—
0
9
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
9
0.00
0.00
0.0
3.4
—
49.6
—
0
9
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
17.2
—
0
9
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
1593.2
—
0
5
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
5.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
27.0
—
0
5
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
46
1.04
0.00
1.6
2.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
9
0.00
0.00
0.0
1.8
—
8.4
—
0
9
(3009542) Hematocrit [Volume Fraction] of Blood
44
420
1.00
0.00
21.9
22.3
%
38.4
38.2
0.12
39
376
(3031040) Bacteria [#/volume] in Urine by Automated count
25
237
1.01
0.00
7.5
3.9
—
27.7
—
0
6
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_OTH_RESPI_COND_ORIGINA_PERINA_PERIOD and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_OTH_RESPI_COND_ORIGINA_PERINA_PERIOD.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_OTH_RESPI_COND_ORIGINA_PERINA_PERIOD – Other respiratory conditions originating in the perinatal period
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data